Author Archives: Warren Woessner

Legal Wiggle Room in the Joint AIPLA-IPO Proposal on Patentability?

I recently took another look at the Joint AIPLA-IPO Proposal on Patent Eligibility that was prompted by the scheduling of a discussion meeting by the Minnesota Intellectual Property Law Association. I confess that I did not participate in either the … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Novartis v. Breckenridge: Obviousness-Type Double Patenting Explained

Without trying to summarize this well-written opinion by Judge Chen, I simply recommend that you store it somewhere and pull it out when you have a tricky obviousness-type double-patenting situation and want a thorough review of the doctrine. The opinion … Continue reading

Posted in Double Patenting, Obviousness | Tagged , , , , , | Leave a comment

IP Update – Canada | New Patent Rules released: 12 Notable Changes & Tips

Guest Post from David Schwartz and Jeff Leuschner of  Smart & Biggar. On December 1, 2018, the Canadian government released its proposed new Patent Rules in the Canada Gazette, Part I. This is one of the last steps necessary for implementing significant changes … Continue reading

Posted in Int'l Practice and Policy | Tagged , , , | Leave a comment

Life Science Patenting to Iancu – “We need help too!”

In his remarks presented at the recent 10th Annual Patent Law & Policy Conference at Georgetown University Law School, USPTO Director Andrei Iancu outlined the analytical framework for the new, eagerly awaited, PTO Guidance on patent eligible subject matter. Although … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , | Leave a comment